Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCF
Assuntos: MATERIAIS NANOESTRUTURADOS, NEOPLASIAS
ABNT
BARBOSA, Eduardo José et al. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. European Journal of Pharmaceutics and Biopharmaceutics, v. 141, p. 58-69, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2019.05.004. Acesso em: 04 out. 2024.APA
Barbosa, E. J., Löbenberg, R., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2019). Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. European Journal of Pharmaceutics and Biopharmaceutics, 141, 58-69. doi:10.1016/j.ejpb.2019.05.004NLM
Barbosa EJ, Löbenberg R, Araujo GLB de, Bou-Chacra NA. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 141 58-69.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.ejpb.2019.05.004Vancouver
Barbosa EJ, Löbenberg R, Araujo GLB de, Bou-Chacra NA. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; 141 58-69.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.ejpb.2019.05.004